Research Bio

Dr. Stefano M. Bertozzi is former dean and professor of health policy and management at the UC Berkeley School of Public Health. Previously, he directed the HIV and tuberculosis programs at the Bill and Melinda Gates Foundation. Dr. Bertozzi worked at the Mexican National Institute of Public Health as director of its Center for Evaluation Research and Surveys. He was the last director of the WHO Global Programme on AIDS and has also held positions with UNAIDS, the World Bank and the government of the DRC.

He is the founding editor-in-chief of Rapid Reviews Infectious Diseases (RRID), an open access, rapid-review overlay journal for the accelerated curation and peer review of infectious disease-related research. He serves or has served on governance and advisory boards for the Bay Area Global Health Alliance, the Tsinghua Vanke School of Public Health, the Global Virus Network, the East Bay Community Foundation, HopeLab, the Institute for Transformative Technologies, UNICEF, WHO, UNAIDS, the Global Fund to Fight AIDS, Tuberculosis and Malaria, PEPFAR, the NIH, Duke University, the University of Washington and the AMA. He has advised NGOs, and ministries of health and social welfare in Asia, Africa and Latin America. He is a member of the National Academy of Medicine. He holds a bachelor’s degree in biology and a PhD in health policy and management from the Massachusetts Institute of Technology. He earned his medical degree at UC San Diego, and trained in internal medicine at UC San Francisco.

Current projects include: 

• Pharmacy provision of PrEP (Tanzania); implementation trial of different delivery models 
• ART resupply in pharmacies (Uganda); clinical trial with Maisha Meds looking at willingness-to-pay for the convenience of pharmacy pick-up
• Northern CA HIV Policy Center (with UCSF); predictors of linkage to care for people living with HIV being released from CDCR
• Pharmacist PrEP prescribing; mixed-methods study of pharmacists to understand why/where they are not participating despite enabling legislation
• Collaborative on the Economics of Psychedelics
• Psychedelic regulation in LMICs; developing an LMIC network of regulatory agencies working on policy for the use of psychedelics to treat mental illness
• Rapid Reviews\Infectious Diseases Journal

Research Expertise and Interest

hiv/aids, hiv prevention, hiv treatment programs, reproductive health, health economics, anti-poverty programs, impact evaluation